Delta 9 Plans Strategic Partnership Alongside Westleaf Cannabis

Delta 9 Cannabis (TSXV:NINE) announced a non-binding letter of intent with Westleaf Cannabis for the joint development of a cannabis production facility in Southern Alberta.
As quoted in the press release:

Pursuant to the terms of the LOI, Delta 9 and Westleaf will each own a 50 per cent equity interest in the Project. The Project includes the retrofit of an existing building intended to be equipped to produce approximately 4,000 kilograms of premium dried cannabis flower per annum, and an extraction lab for the production of cannabis oil and derivative products. Delta 9 anticipates designating the Project as an expansion facility under its existing Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license. The Project is expected to be operational as early as the third quarter of 2018 and is intended to supply cannabis products to the Alberta medical and recreational markets.
The completion of the Project remains subject to a number of conditions including, among other things: the execution of a definitive, binding agreement between Delta 9 and Westleaf; the parties obtaining the debt and equity financing required to complete the Project; and the completion of due diligence regarding the Project by Delta 9 and Westleaf.
“We are excited about this transformational opportunity,” said Delta 9 CEO John Arbuthnot. “Strategic partnerships with companies such as Westleaf provide Delta 9 with additional production capacity and expansion opportunities into new markets to meet increasing demand as we approach the legalization of recreational cannabis this summer.”

Click here to read the full press release.

Source: www.newswire.ca